 Before the 3.2 billion acquisition of mRNA player Translate Bio Inc NASDAQ: TBIO earlier this month, Sanofi SA NASDAQ: SNY expressed interest in selling off around 25 of its shares in the company, which it had been working with since 2018. Translate Bio filed SEC document to give an inside look at how the buyout negotiations played out. 